Alexander Shapsis, MD is a board-certified gastroenterologist and medical weight-loss specialist with extensive experience treating obesity and metabolic disorders using GLP-1 therapies, including semaglutide (Ozempic and Wegovy) and tirzepatide
Hara KY, Shimodate N, Ito M, Baba T, Mori H, Mori H
The most significant regulatory development is the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) , which took effect January 1, 2026
If your insurance demands prior authorization, our team will handle the entire process for you, including preparing medical documentation and dealing with your insurer
If PLP is normal or low, investigate other causes including B12 deficiency, thiamine deficiency, or diabetes-related neuropathy